Glassman Wealth Services Ptc Therapeutics, Inc. Transaction History

Glassman Wealth Services

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$25.6 - $45.23 $128 - $226	-5 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $459 - $544	-13 Reduced 72.22%	5 $0
Q3 2021 Nov 10, 2021	BUY	$37.01 - $44.74 $185 - $223	5 Added 38.46%	18 $1,000
Q2 2021 Aug 04, 2021	BUY	$37.95 - $49.37 $189 - $246	5 Added 62.5%	13 $1,000
Q1 2021 May 05, 2021	BUY	$46.8 - $68.92 $140 - $206	3 Added 60.0%	8 $0
Q1 2020 May 12, 2020	BUY	$32.37 - $59.36 $161 - $296	5 New	5 $0
Q4 2019 Feb 07, 2020	SELL	$32.22 - $50.07 $161 - $250	-5 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$35.42 - $45.0 $177 - $225	5 New	5 $0

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.